Famed geneticist George Church has spun out another company – this one developing cell therapies that regenerate the thymus, thereby restoring and improving immune function.
Thymmune Therapeutics debuted Wednesday with $7 million in seed financing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,